Cargando…
GS-9219/VDC-1101 - a prodrug of the acyclic nucleotide PMEG has antitumor activity inspontaneous canine multiple myeloma
BACKGROUND: Multiple myeloma (MM) is an important human and canine cancer for which novel therapies remain necessary. VDC-1101 (formerly GS-9219), a novel double prodrug of the anti-proliferative nucleotide analog 9-(2-phosphonylmethoxyethyl) guanine (PMEG), possesses potent cytotoxic activity in vi...
Autores principales: | Thamm, Douglas H, Vail, David M, Kurzman, Ilene D, Babusis, Darius, Ray, Adrian S, Sousa-Powers, Noel, Tumas, Daniel B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904015/ https://www.ncbi.nlm.nih.gov/pubmed/24460928 http://dx.doi.org/10.1186/1746-6148-10-30 |
Ejemplares similares
-
Phase II Evaluation of VDC‐1101 in Canine Cutaneous T‐Cell Lymphoma
por: Morges, M.A., et al.
Publicado: (2014) -
VDC Monitoring Tools
por: Porat, Itay Gershon
Publicado: (2017) -
A novel lipid prodrug strategy for sustained delivery of hexadecyloxypropyl 9-[2-(phosphonomethoxy)ethyl]guanine (HDP-PMEG) on unwanted ocular proliferation
por: Chen, Mei, et al.
Publicado: (2017) -
Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets
por: Cox, Robert M., et al.
Publicado: (2021) -
Measurements of the Drift Velocity in Drift Velocity Chambers (VDC)
por: Arps, Jennifer
Publicado: (2017)